Literature DB >> 2574262

Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria.

N J White1, S Krishna, D Waller, C Craddock, D Kwiatkowski, D Brewster.   

Abstract

An open paired randomised comparison of intramuscular chloroquine (3.5 mg base/kg every 6 h) and intramuscular quinine (20 mg salt/kg followed by 10 mg/kg every 12 h) was carried out in 50 Gambian children with severe falciparum malaria. 8 children died, 6 from the quinine-treated and 2 from the chloroquine-treated group. Chloroquine reduced parasitaemia significantly more rapidly than did quinine, but other measures of the therapeutic response were similar in the two groups. Quinine injections were painful. These findings do not support the proposition that quinine is intrinsically superior to chloroquine in the treatment of severe drug-sensitive falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574262     DOI: 10.1016/s0140-6736(89)91918-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.

Authors:  E Pussard; J P Lepers; F Clavier; L Raharimalala; J Le Bras; M Frisk-Holmberg; Y Bergqvist; F Verdier
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 2.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.

Authors:  P A Winstanley; W M Watkins; C R Newton; C Nevill; E Mberu; P A Warn; C M Waruiru; I N Mwangi; D A Warrell; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

4.  Therapeutic responses to different antimalarial drugs in vivax malaria.

Authors:  S Pukrittayakamee; A Chantra; J A Simpson; S Vanijanonta; R Clemens; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 6.  High first dose quinine regimen for treating severe malaria.

Authors:  A Lesi; M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs.

Authors:  W Supanaranond; T M Davis; S Pukrittayakamee; B Nagachinta; N J White
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  The parasite clearance curve.

Authors:  N J White
Journal:  Malar J       Date:  2011-09-22       Impact factor: 2.979

9.  Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.

Authors:  A Ratcliff; H Siswantoro; E Kenangalem; M Wuwung; A Brockman; M D Edstein; F Laihad; E P Ebsworth; N M Anstey; E Tjitra; R N Price
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-10-09       Impact factor: 2.184

Review 10.  The role of anti-malarial drugs in eliminating malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.